Skip to content

Clinical trials

Phase 2 Hyperthyroidism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperthyroidism Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20141
20161
20191
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Immunovant Sciences GmbH2
Biogen1
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northwell Health1
Novartis Pharmaceuticals1
Sun Yat-sen University1
Tourmaline Bio, Inc., a Novartis Company1
University of Florida1
Yarrow Bioscience, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperthyroidism11
Graves Disease10
Graves Ophthalmopathy3
Thyroid Diseases2
Autoimmune Diseases1
Endocrine System Diseases1
Exophthalmos1
Eye Diseases1
Eye Diseases, Hereditary1
Hypothyroidism1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.